Company intelligence / Profile preview
Journey Medical Corporation
Scottsdale, Arizona, United Statesjourneymedicalcorp.com ↗
- Ownership
- Public · DERM
- Employees
- ~41
- Development stage
- Other
01
Overview
Journey Medical Corporation markets FDA-approved prescription pharmaceutical products for dermatological conditions. Their most recent approval is Emrosi (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for treating inflammatory lesions of rosacea in adults, approved in November 2024.
- Therapeutic areas
- DermatologyInfectious Diseases
- Modalities
- Small moleculestopical formulationsoral medications
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Dr. Reddy's Laboratories Ltd. (for Emrosi development)
04
Financials
- Market cap
- $121.4M
- Total revenue
- $61.9M
- Enterprise value
- $121.3M
Beyond the preview
Go deeper on Journey Medical Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Journey Medical Corporation.